PPARG and polycystic ovary syndrome: In a third randomized, double-blind, placebo-controlled clinical trial, Jamilian et al. randomly assigned 54 PCOS women to receive either chromium and carnitine co-supplementation or placebo and again highlighted that the above co-supplementation increased PPARγ gene expression [109].